1. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes;Coleman;Pharmacol. Rev.,1994
2. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2α analog, PhXA41 (latanoprost), for glaucoma management;Bito;J. Lipid Mediators,1993
3. Pharmacological characterization of an FP prostaglandin receptor on rat vascular smooth muscle cells (A7r5) coupled to phosphoinositide turnover and intracellular calcium mobilization;Griffin;J. Pharmacol. Exp. Ther.,1998
4. Effects of PGF2α and carbachol on MAP kinases, cytosolic phospholipase A2 and arachidonic acid release in cat iris sphincter smooth muscle cells;Husain;Exp. Eye Res.,2001
5. Role of p42/p44 MAP kinases and calcium-dependent calmodulin kinases II in PGF2α, ionomycin, and thapsigargin-induced muscle contraction in cat iris sphincter smooth muscle;Ansari;J. Pharmacol. Exp. Ther.,2001